Commercial production will start in the first quarter of 2011.
Saudi Arabia’s Health Ministry plans to set up a pharmaceutical factory in Mecca to produce vaccines against common diseases, Arab News has reported. The factory is to produce vaccines for meningitis, seasonal influenza, whooping cough, diphtheria, tetanus, Haemophilus influenza, Hepatitis B and others. Novartis Pharmaceutical is expected to supervise the transfer of technology and also manufacture of the vaccines during the next two decades. The facility is scheduled to commence commercial production in the first quarter of 2011.
You might also like...
Global AI market to top $1tn in 2030
25 April 2024
Morocco tenders Noor Midelt 2
25 April 2024
Saudi Arabia's Roshn launches Aldanah Dhahran project
25 April 2024
Kuwait retenders revegetation contracts
25 April 2024
A MEED Subscription...
Subscribe or upgrade your current MEED.com package to support your strategic planning with the MENA region’s best source of business information. Proceed to our online shop below to find out more about the features in each package.